CSI Market
Sign In | Register

Cyteir Therapeutics Inc (CYT) Annual Balance Sheets

Annual · GAAP · USD millions
Access CYT quarterly Balance Sheets →
Examining balance sheet movements between Cyteir Therapeutics Inc and Dec 31 2012 reveals how Dec 31 2022 adjusts its asset composition and liability profile.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Dec 31 2021) (Dec 31 2014) (Dec 31 2013) (Dec 31 2012)
Assets
Cash & cash equivalent147.12
Cash & Short-term Investments147.00
Accounts receivable0.00
Inventories0.00
Assets Held For Sale Current0.00
Other Current Assets0.00
Deferred Tax Assets, Net of Valuation Allowance, Current0.00
Prepaid Expense And Other Assets Current2.09
Total Current Assets149.21
Equipment/Property/Plant Net1.70
Goodwill net0.00
Intangible Assets0.00
Long-term investments0.00
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent0.00
Assets Held For Sale Other Noncurrent0.00
Other Assets, Noncurrent2.32
Total Assets153.23
Liabilities
Accounts Payable, Current AC1.13
Accrued Liabilities, Current AC0.00
Short-term Debt DE10.00
Other Liabilities, Current4.19
Taxes Payable0.00
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.00
Total Current Liabilities5.32
Long-term debt0.00
Total Long-term Debt0.00
Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent PE0.00
Deferred Rent Credit, Noncurrent DE0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI0.00
Other liabilities, Noncurrent1.63
Total Liabilities6.95
Stockholders' Equity
Common Stock Value0.04
Treasury Stock Value0.00
Additional Paid In Capital Common Stock284.37
Retained Earnings / Accumulated Deficit-138.11
Other Equity0.00
Common Stockholder's Equity146.29
Non-controlling interests & other0.00
Total Stockholder's Equity146.29
Liabilities & Stockholder's Equity153.23
4 historic quarters locked

Sign in to unlock the full Cyteir Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Cyteir Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-059370

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License